GH1 and neoplasm: In univariate regression analyses, the peak GH response to GHRP-2 significantly and negatively correlated with BMI, serum creatinine level, and tumor diameter, and it was positively correlated with estimated GFR, IGF-1 SD score, and free thyroxine levels (Fig 2).